Indications of Intravenous Immunoglobulin Use

Project Title Indications of Intravenous Immunoglobulin Use
Date Posted
Friday, May 20, 2016
Status
Complete
Deliverables
Mini-Sentinel Modular Program Report: Indications of Intravenous Immunoglobulin Use
Description

Modular program-based one-time assessment of the indications for use of intravenous immunoglobulin products. The query was run against the Mini-Sentinel Distributed Database (MSDD) for the time period of January 1, 2006 to June 30, 2012.  Modular programs are adaptable standardized programs. Results were generated using Modular Program 7; click here for more information.  Queries were distributed in February 2013. This report includes data from 18 Data Partners.
 
If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.
 
The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

Medical Product
intravenous immunoglobulin (IVIg)
Time Period
January 1, 2006 -July 30, 2012
Assessment Type
Exploratory Analyses
Study Type
Modular Program
Data Sources
Mini-Sentinel Distributed Database (MSDD)
FDA Center
CDER
Scroll to Top